Hank Fuchs, MD

At the National Organization for Rare Disorders (NORD) Rare Diseases and Orphan Products Breakthrough Summit, Dr. Hank Fuchs, Chief Medical Officer at BioMarin Pharmaceuticals, discusses how industry thinking has evolved with regard to drug development for rare diseases.